Truist raised the firm’s price target on Guardian Pharmacy (GRDN) to $24 from $22 and keeps a Buy rating on the shares. The firm is adjusting its model after the company’s Q3 results and FY24 guidance ...
The average one-year price target for Guardian Pharmacy Services (NYSE:GRDN) has been revised to $34.68 / share. This is an increase of 17.24% from the prior estimate of $29.58 dated November 7, 2025.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results